1,232 results on '"Hoogeveen, Ron"'
Search Results
2. Contributors
3. Emerging Assays for Risk Assessment
4. Associations of urinary isoprostanes with measures of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
5. Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study
6. Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation
7. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk
8. Dynamic and functional linkage between von Willebrand factor and ADAMTS-13 with aging: an Atherosclerosis Risk in Community study
9. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study
10. Abstract 18742: Matrilysin (MMP7) as a Robust Predictor of Hypertension Incidence and Complications: Findings From a Proteomic Analysis in the Atherosclerosis Risk in Communities (ARIC) Study
11. Abstract 17635: Proteomic Signatures of Diabetes-Related Coronary Heart Disease: The Atherosclerosis Risk in Communities Study
12. Abstract 17003: Associations of SGLT2 Inhibitor-Related Plasma Proteins With Incident Heart Failure: The Atherosclerosis Risk in Communities Study
13. Abstract 16931: Network Analysis Identifies Partially Distinct Plasma Protein Associations Underlying HFpEF and HFrEF
14. Abstract 16835: Plasma Proteomics and Risk of Incident HFpEF and HFrEF: The Atherosclerosis Risk in Communities Study
15. Abstract 15895: Bariatric Surgery and Subclinical Myocardial Injury
16. Abstract 15669: Proteomic Associations With Late-Life Cardiac Structure and Function: The Atherosclerosis Risk in Communities Study
17. Abstract 14629: Assessing the Contribution of Racial Differences in Elevated Lipoprotein (a) Levels to Disparities in Atherosclerotic Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study
18. Abstract 14024: Proteomic Predictors of Transitioning From Metabolically Healthy to Unhealthy Status in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study
19. Abstract 13711: Clonal Hematopoiesis Driven by TET2 and ASXL1 but Not DNMT3A is Associated With Interleukin 6 Levels, Cardiac Biomarkers, Cardiac Remodeling, and Risk of Atrial Fibrillation
20. Abstract 13259: Large-Scale Plasma Proteomics Identifies C1QTNF1 as a Potential Causal Risk Factor for Aortic Stenosis
21. Abstract 13260: Large Scale Plasma Proteomics Identifies MMP-12 as a Novel Biomarker of Aortic Stenosis Progression
22. MMP-2 Associates With Incident Heart Failure and Atrial Fibrillation: The ARIC Study
23. Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome
24. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study
25. Associations of urinary isoprostanes with measures of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
26. Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project
27. Associations of mid‐to‐late‐life inflammation with late‐life mobility and the influences of chronic comorbidities, race, and social determinants of health: The Atherosclerosis Risk in Communities Study
28. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1
29. Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology
30. Diabetes, GDF-15 and incident heart failure: the atherosclerosis risk in communities study
31. Elevated NT-ProBNP as a Cardiovascular Disease Risk Equivalent: Evidence from the Atherosclerosis Risk in Communities (ARIC) Study
32. Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay.
33. NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
34. NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.
35. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study
36. Lipoprotein-associated phospholipase A2 and risk of incident peripheral arterial disease: Findings from The Atherosclerosis Risk in Communities study (ARIC)
37. A polygenic risk score of atrial fibrillation improves prediction of lifetime risk for heart failure
38. Abstract 12892: Cumulative Weight, Adipokines, and Hypertension
39. Abstract 12287: Adipokines and Transitions in Metabolic Risk Over Time: The Atherosclerosis Risk in Communities (ARIC) Study
40. Abstract 12229: Adipokines Are Linked to Heart Failure Through Metabolic Risk-Dependent and Independent Pathways: The Atherosclerosis Risk in Communities (ARIC) Study
41. Abstract 11125: Association of Interleukin-6 and Interleukin-18 With Global Cardiovascular Disease in Older Adults
42. Abstract 10296: Relation of Lipoprotein(a) to Progression of Coronary Artery Calcium: Results From a Pooled Cohort of Mesa, Cardia, and Framingham Offspring Studies
43. Abstract 10288: Lipoprotein(a) and Long-Term Risk of Atherosclerotic Cardiovascular Disease in a US Pooled Cohort
44. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)
45. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study
46. Detection of genetic loci associated with plasma fetuin-A: a meta-analysis of genome-wide association studies from the CHARGE Consortium
47. Association of mid-life serum lipid levels with late-life brain volumes: The atherosclerosis risk in communities neurocognitive study (ARIC[sbnd]NCS)
48. Nonalcoholic Fatty Liver Disease and Longitudinal Change in Imaging and Plasma Biomarkers of Alzheimer Disease and Vascular Pathology.
49. Liver integrity and the risk of Alzheimer's disease and related dementias
50. High-Sensitivity Cardiac Troponins I and T and Cardiovascular Outcomes: Findings from the Systolic Blood Pressure Intervention Trial (SPRINT)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.